<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Chitramuthu et al. Molecular Neurodegeneration 2010, 5:41 <br /> http://www.molecularneurodegeneration.com/content/5/1/41 <br />  <br />  <br />  <br />  <br />  RESEARCH ARTICLE                                                                                                                            Open Access <br />  <br /> Progranulin modulates zebrafish motoneuron <br /> development vivo rescues truncation <br /> defects associated knockdown <span id='am-5' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-6' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-7' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-8' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-9' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-10' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-11' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-14' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-16' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-17' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-18' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-20' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-22' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-23' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-24' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-25' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-28' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-29' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-30' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-32' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-35' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-37' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-38' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-39' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-40' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-41' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-42' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-45' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-47' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-49' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-50' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-51' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-52' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-53' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-54' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-55' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-56' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-57' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-58' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-59' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-60' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-61' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-62' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-63' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-65' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-66' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-67' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-68' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-69' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-70' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-71' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-72' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-75' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-76' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-77' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-78' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-79' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-81' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-82' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span>Survival</span> <br /> motor neuron 1 <br /> Babykumari P Chitramuthu1,2, David C Baranowski2, Denis G Kay2, Andrew Bateman1, Hugh PJ Bennett1* <br />  <br />  <br />   <span id='am-1' about='protege:abstract' typeof='owl:Thing'>Abstract</span> <br />   Background: Progranulin (PGRN) encoded GRN gene, secreted glycoprotein growth factor has <br />   implicated physiological pathophysiological processes. PGRN haploinsufficiency caused by <br />   autosomal dominant mutations GRN gene leads progressive neuronal atrophy form of <br />   frontotemporal lobar degeneration (FTLD). This form disease associated neuronal inclusions bear <br />   ubiquitinated TAR DNA Binding Protein-43 (TDP-43) molecular signature (FTLD-U). The neurotrophic properties <br />   PGRN vitro recently reported role PGRN neurons understood. Here we <br />   document neuronal expression functions PGRN spinal cord motoneuron (MN) maturation and <br />   branching vivo using zebrafish, established model vertebrate embryonic development. <br />   Results: Whole-mount situ hybridization immunohistochemical analyses zebrafish embryos revealed that <br />   zfPGRN-A expressed peripheral central nervous systems including caudal primary (CaP) MNs <br />   spinal cord. Knockdown zfPGRN-A mRNA translation mediated antisense morpholino <br />   oligonucleotides disrupted normal CaP MN development resulting truncated MNs inappropriate early <br />   branching. Ectopic over-expression zfPGRN-A mRNA resulted increased MN branching rescued the <br />   truncation defects brought knockdown zfPGRN-A expression. The ability PGRN interact with <br />   established MN developmental pathways tested. PGRN over-expression reverse truncation <br />   defect resulting knockdown Survival motor neuron 1 (smn1). This involved small ribonucleoprotein <br />   biogenesis RNA processing, mutations cause Spinal Muscular Atrophy (SMA) humans. It did reverse <br />   MN defects caused interfering neuronal guidance pathway knockdown expression NRP-1, <br />   semaphorin co-receptor. <br />   Conclusions: Expression PGRN MNs observed phenotypes resulting mRNA knockdown and <br />   over-expression consistent role regulation spinal cord MN development branching. This <br />   study presents vivo demonstration neurotrophic properties PGRN suggests possible future <br />   therapeutic applications treatment neurodegenerative diseases. <br />  <br />  <br /> Background                                                                          glycoprotein contains multiple linear repeats the <br /> Progranulin (PGRN) (also called granulin-epithelin pre-                             disulfide-rich granulin motif [1]. PGRN implicated in <br /> cursor, PC-derived growth factor, transforming growth                               numerous physiological disease processes [2] <br /> factor-e, acrogranin proepithelin) secreted                                 including early development embryo [3-6], wound <br />                                                                                     healing [7], inflammation [8,9], chondrogenesis [10] and <br /> * Correspondence: hugh.bennett@mcgill.ca                                            cancer (reviewed [2]). While long known <br /> 1 <br />  Endocrine Research Laboratory Department Medicine, Royal Victoria           PGRN expressed neurons adult and <br /> Hospital McGill University Health Centre Research Institute, Montreal,          developing murine nervous [11], roles PGRN <br /> Quebec, H3A 1A1, Canada <br /> Full list author information available end article              CNS recently emerged. GRN mutations <br />  <br />                                        &#194;&#169; 2010 Chitramuthu et al; licensee BioMed Central Ltd. This Open Access article distributed terms Creative <br />                                        Commons Attribution License (http://creativecommons.org/licenses/by/2.0), permits unrestricted use, distribution, and <br />                                        reproduction medium, provided original work properly cited. <br />  Chitramuthu et al. Molecular Neurodegeneration 2010, 5:41                                                     Page 2 13 <br /> http://www.molecularneurodegeneration.com/content/5/1/41 <br />  <br />  <br />  <br />  <br /> cause progressive neurodegenerative disease,          affects neuronal survival development vivo. This <br /> frontotemporal lobar degeneration associated ubi-         clearly important question given devastating <br /> quitin inclusions (FTLD-U). FTLD-U belongs              clinical effects partial loss PGRN expression in <br /> subset neurodegenerative diseases character-       FTLD patients. Here employed zebrafish animal <br /> ized histologically ubiquitin-positive cytoplasmic      model investigate issue. <br /> intranuclear neuronal inclusions containing TAR               The zebrafish (Danio rerio) emerged powerful <br /> DNA binding protein, TDP-43 [12,13]. Familial FTLD          tool study early developmental events, define gene <br /> heterogeneous addition GRN mutations,           function model human disease [31]. Unlike the <br /> arise mutations MAPT, gene encoding            mammalian genome contains single GRN <br /> Tau protein. However, variant differs histologically      gene, zebrafish possesses distinct GRN genes. <br /> <span id='am-2' about='protege:FROM' typeof='owl:Thing'>from</span> FTLD-U displaying Tau aggregation lacking          Two genes, grna grnb resemble <br /> ubiquitinated TDP-43 inclusions [14]. <span id='am-4' about='protege:TO' typeof='owl:Thing'>To</span> date 68 patho-        mammalian GRN possessing multiple tandem repeats <br /> genic autosomal dominant mutations                   GRN motif. Syntenic conservation gene locali- <br /> reported occur GRN gene [15]. The majority           zation suggests these, grna true orthologue <br /> are nonsense mutations lead introduction        human GRN gene [32,33] the <br /> premature stop codons resulting elimination          major focus study. In previous studies have <br /> nascent PGRN mRNA process nonsense              identified central spinal cord motoneurons as <br /> mediated decay [14,16]. FTLD-U usually manifests initi-        highly PGRN-expressing cells the <br /> ally behavioral linguistic defects [17-19],   murine nervous demonstrated cytoprotec- <br /> while predominantly early onset form demen-        tive action PGRN MN-like cells vitro [30]. <br /> tia, age inception highly variable ranging      This prompted examination PGRN MN devel- <br /> 35-85 years [20]. This highly variable age-dependent           opment zebrafish. <br /> penetrance suggests actions PGRN influ-           During 24 hours post-fertilisation (hpf) in <br /> enced gene products possibly environmen-          zebrafish primary caudal (CaP), mid (MiP), rostral <br /> tal factors. FTLD-U invariably fatal effective       (RoP) motor neurons initially share common pathway. <br /> treatment exists present [21].                              This developmental period encompassed our <br />   Many neurodegenerative conditions associated             studies. Normal CaP neurons rarely branch the <br /> with accumulation toxic protein aggregates              horizontal myoseptum (HM) [34], assembly mus- <br /> including amyloid, tau-fibrils, synuclein huntingtin       cle pioneer cells serves transient target for <br /> [22,23]. The role PGRN FTLD-U different            developing primary motoneurons prior develop- <br /> that primary cause disease partial loss       ment axonal projections extend target <br /> PGRN protein levels [19]. This results ultimately neu-      populations muscles cells. The CaP neurons develop <br /> ronal cell death details occurs       extend ventrally horizontal myo- <br /> are understood. While Grn-deficient mice           septum branching promotes functional contact <br /> not appear develop overt FTLD, recent studies            myotome. The development CaP neurons <br /> <span id='am-317' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-318' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-319' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-320' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-321' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-322' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-323' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-324' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-325' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-326' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-327' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-328' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-329' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-330' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-331' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-332' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-333' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-334' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-335' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-336' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-337' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-338' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-339' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-340' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-341' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-342' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-343' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-344' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-345' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-346' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-347' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-348' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-349' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-350' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-351' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-352' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-353' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-354' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-355' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-356' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-357' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-358' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-359' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-360' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-361' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-362' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-363' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-364' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-365' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-366' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-367' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-368' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-369' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-370' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-371' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-372' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-373' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-374' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-375' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-376' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-377' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-378' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-379' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-380' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-381' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-382' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-383' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-384' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-385' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-386' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-387' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-388' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-389' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-390' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-391' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-392' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-393' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-394' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span>knockout</span> mice emphasize vulnerable neuronal tis-           characterized experimental model study <br /> sue low PGRN levels. The sensitivity hippocam-        mechanisms regulate MN axonal development and <br /> pal neurons hypoxia-induced cell death increased         projection [34]. Axonal projection branching are <br /> [24] exhibit enhanced aggressiveness anxi-        readily visualized embryo whole-mounts anti- <br /> ety consistent alterations brain development           sense mRNA knockdown factors specifically dis- <br /> [25]. Furthermore, PGRN implicated             rupt CaP development reported [35,36]. <br /> male-specific differentiation murine hypothalamus       Growth cone guidance provided secreted factors <br /> [26]. PGRN deficient mice display exaggerated               including semaphorins, netrins ephrins [37]. MN <br /> inflammatory response exposure Listeria mono-          differentiation survival influenced mor- <br /> cytogenes chronic infection time leads             phogens humoral factors including IGF [38], <br /> greater activation microglia astrocytes resul-      Wnt Shh signaling [39]. Our results suggest <br /> tant neuronal damage [24]. Progranulin deficient mice          PGRN play role regulating these <br /> display range behavioural deficits progressive        processes. <br /> neuropathological defects [27]. Knockout mice dis- <br /> play increased neuronal lipofuscinosis ubiquitination      Results <br /> as age suggesting critical role PGRN           Zebrafish progranulin-A expressed Central <br /> long-term neuronal survival factor [28]. We, others,       Nervous System (CNS) Peripheral Nervous System (PNS) <br /> have shown PGRN neuroprotective vitro               In initial studies zebrafish PGRN (zfPGRN) <br /> [29,30], little currently known PGRN          expression [32] demonstrated general <br />  Chitramuthu et al. Molecular Neurodegeneration 2010, 5:41                                                                            Page 3 13 <br /> http://www.molecularneurodegeneration.com/content/5/1/41 <br />  <br />  <br />  <br />  <br />  Figure 1 Zebrafish PGRN-A situ expression Spinal cord MNs. Lateral view 24-27 hpf embryos revealed zfPGRN-A expression <br />  Peripheral Central Nervous systems. In head region, zfPGRN-A expressed 24 hpf head brain particularly the <br />  tectum, midbrain-hindbrain boundary eye (Panel A). The sense control displayed minimal signal (Panel B). In addition zfPGRN-A also <br />  expressed 27 hpf somite boundaries (Panel C). At greater magnification boxed area Panel C, zfPGRN-A expression the <br />  somite boundaries apparent expression motoneurons (Panel D). Abbreviations: T: Tectum; E:Eye, MHB:Mid-Brain, <br />  Hind-brain Boundary; SB:Somite Boundary, MN:Motoneurons; ICM: Intermediate cell mass. Images captured 6X magnification the <br />  hatched box subject 2-3X Zoom <br />  <br />  <br /> neural expression zfPGRN-A hindbrain                         zfPGRN-A knockdown results disrupted development <br /> tectum 24 hpf. Given high expres-                     multiple neural structures <br /> sion PGRN murine MNs investigated                                 Antisense morpholino (MO) technology employed <br /> zfPGRN-A expression using mount situ                              investigate function zfPGRN-A neural devel- <br /> hybridization 27 hpf specific emphasis                          opment knocking gene expression injection <br /> expression MNs (Figure 1, Panels A C).                          oligonucleotides zebrafish embryos 1 2 <br /> Expression zfPGRN-A detected neural                          cell stage. Two independent zfPGRN-A MO were <br /> development retina, hindbrain, tectum, spinal                       employed inhibit zfPGRN-A translation directed <br /> cord caudal primary (CaP) motoneuron (MNs). At                         zfPGRN-A ATG (designated MO1) <br /> 27 hpf zfPGRN-A expression detected                        5&#226;&#8364;&#178;UTR (designated MO2). Titration con- <br /> somite boundaries, potential source factors influ-                    centration injected zfPGRN-a MO2 zfPGRN- <br /> encing MN development (Figure 1, Panel C D).                           A levels demonstrated 10 ng/embryo the <br /> A similar tissue-distribution <span id='am-396' about='xsp:pattern' typeof='owl:Thing'>pattern</span> observed                     zfPGRN-A MO effectively decreased zfPGRN-A transla- <br /> immunoreactive zfPGRN-A using mount immu-                            tion (Figure 3, Panel A) affecting expression <br /> nofluorescence (Figure 2, Panels A, D, C F). Con-                      orthologue zfPGRN-B. Injection equivalent <br /> trol experiments primary antibody                             5 <span id='am-395' about='xsp:base' typeof='owl:Thing'>base</span>-pair mismatch control morpholino <br /> replaced normal calf serum eliminate pos-                      (mm) equivalent scrambled sequence (scr) <br /> sibility non-specific staining did produce                       resulted little decrease zfPGRN-A expression <br /> immunoreactive signal (data shown). The expres-                        (Figure 3, Panel A). Co-injection zfPGRN-A-MO with <br /> sion zfPGRN-A MNs con-                           zfPGRN-A mRNA restored zfPGRN-A protein levels <br /> firmed co-localization znp1, marker                      (Figure 3, Panel B). The efficacy translation from <br /> MNs (Figure 2, Panels B, C, E F). These observa-                       injected mRNA confirmed injection hPGRN <br /> tions consistent murine neural expression                      mRNA control green fluorescent protein (gfp) mRNA <br /> PGRN development [11].                                              shown Western blot translated into <br />  Chitramuthu et al. Molecular Neurodegeneration 2010, 5:41                                                                        Page 4 13 <br /> http://www.molecularneurodegeneration.com/content/5/1/41 <br />  <br />  <br />  <br />  <br />  Figure 2 Colocalization zfPGRN-A znp1 immunoreactivity Primary motor neurons 27 hpf. Lateral views (anterior- left; dorsal- <br />  top) whole-mount embryos labelled zfPGRN-A (A, D) znp1 mAb (B, E) 27 hpf. Embryos zfPGRN-A expression developing <br />  eye, tectum hindbrain (A); Spinal Cord, Somite boundaries motor neurons (D); znp1 expression eye, hindbrain, Spinal Cord and <br />  motor neurons (B E). Merged images co-localization zfPGRN-A znp1 (C, F). Abbreviations: T, Tectum; E, Eye; MHB, Mid-Brain <br />  Hindbrain Boundary; SB, Somite boundary; MN, Motoneurons.; SC, Spinal cord. Images captured 20 &#195;&#8212; magnification. Scale Bar = 50 &#206;&#188;m. <br />  <br />  <br />  <br />  <br /> protein products (Figure 3, Panel C). GFP translation                   aberrant branching. Both wild type embryos <br /> was observed embryo (Additional                          injected control morpholino (MO) normal <br /> File 1). Embryonic injection 10 ng zfPGRN-A MO                       CaP MN development (Figure 5, Panels A B; <br /> resulted disrupted development multiple neural                    Figure 6). Knockdown zfPGRN-A caused truncation <br /> structures 36 hpf (assessed islet-1 expression)              frequent premature branching CaP MNs proxi- <br /> was partially rescued co-injection zfPGRN-A                     mal HM 27 hpf (Figure 5, Panels E F). <br /> mRNA (Figure 4). The expression pattern, knockdown                      The incidence truncated premature <br /> and rescue experiments suggest roles PGRN CNS                    branching CaP motoneurons generated PGRN-A <br /> development.                                                            knockdown significant compared embryos <br />                                                                         injected control MO wild type embryos <br /> Knockdown PGRN-A expression generates defects                     (Figure 6). To evaluate reduction zfPGRN- <br /> motoneuron development                                                  B expression disrupts formation neural struc- <br /> We visualized development CaP neurons                     tures motoneuron development knocked down <br /> whole mount embryos 27 hpf immunostaining                         zfPGRN-B using MO directed UTR <br /> using znp1 monoclonal antibody labels pri-                     region PGRN-B. The depletion PGRN-B pro- <br /> mary MNs (Figure 5). Data sets presented lat-                    duced severe <span id='am-161' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-162' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-163' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-164' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-165' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-166' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-167' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-168' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-169' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-170' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-171' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-172' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-173' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-174' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-175' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-176' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-177' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-178' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-179' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-180' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-181' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-182' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-183' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-184' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-185' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-186' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-187' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-188' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-189' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-190' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-191' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-192' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-193' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-194' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-195' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-196' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-197' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-198' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-199' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-200' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-201' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-202' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-203' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-204' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-205' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-206' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-207' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-208' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-209' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-210' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-211' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-212' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-213' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-214' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-215' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-216' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-217' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-218' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-219' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-220' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-221' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-222' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-223' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-224' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-225' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-226' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-227' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-228' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-229' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-230' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-231' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-232' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-233' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-234' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-235' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-236' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-237' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-238' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span>phenotype</span> notably including reduc- <br /> eral images developing primary MNs                      tion head size seen 24 hpf (data shown). <br /> three somatic hemisegments 12-13                         This consistent high levels mRNA pro- <br /> found developing embryo. This occurs                         vided maternally newly fertilised egg the <br /> both sides body accounts apparent                    extensive expression zfPGRN-B throughout <br /> image duplication seen images. This                    larval brain. These observations make difficult to <br /> seen example panels shown                      analyze possible role zfPGRN-B motoneuron <br /> Figure 5. CaP MNs scored truncation                        development time. <br />  Chitramuthu et al. Molecular Neurodegeneration 2010, 5:41                                                              Page 5 13 <br /> http://www.molecularneurodegeneration.com/content/5/1/41 <br />  <br />  <br />  <br />  <br />                                                                        Knockdown zfPGRN-A impedes avoidance swim <br />                                                                        response <br />                                                                        To determine motoneuron defects observed <br />                                                                        zfPGRN-A expression depleted manifest <br />                                                                        functional defects tested embryo touch <br />                                                                        response avoidance swimming behaviour 48 hrs post <br />                                                                        injection. While touch response unaltered, PGRN- <br />                                                                        A deficient embryos marked swimming defect. <br />                                                                        Embryos strong avoidance swimming <br />                                                                        phenotype typical wild-type embryos. At 72 hrs post <br />                                                                        injection motility zfPGRN-A deficient embryos is <br />                                                                        reduced defect worsens progres- <br />                                                                        sively 48 hpf. This suggests no <br />                                                                        major sensory deficit motor deficit possibly due <br />                                                                        defective innervation MNs PGRN-A knock- <br />                                                                        embryos (Additional File 2, Supplementary Table <br />                                                                        S1; Additional Files 3, 4, 5, 6, Supplementary Videos 1- <br />  Figure 3 zfPGRN-A knockdown, rescue over-expression. (A) <br />  Dose-dependent efficacy morpholino (MO2) targeting 5&#226;&#8364;&#8482; UTR <br />                                                                        4;). The defect rescued co-injection either <br />  zfPGRN-A assessed Western blot analysis comparison    zfPGRN-A hPGRN-A zfPGRN-A MO1 <br />  co-orthologue zfPGRN-B actin. zfPGRN-A B              (Additional File 2, Supplementary Table S1; Additional <br />  represented single bands approximately 55 30 kDa,           Files 7 8, Supplementary Videos 5 6). The major- <br />  respectively. The Western blot analysis MO knockdown efficacy   ity embryos over-expressing zfPGRN-A or <br />  representative independent injection sets. (B) Western <br />  blot analysis protein extracts embryos injected 10 ng <br />                                                                        hPGRN-A strong avoidance swimming pheno- <br />  zfPGRN-A MO1, 10 ng zfPGRN-A MO2, zfPGRN-A-MO2         type typical wild-type embryos (Additional File 2, Sup- <br />  zfPGRN-A mRNA. Injection 10 ng/embryo zfPGRN-A         plementary Table S1; Additional Files 9 10, <br />  MO1 MO2 effectively decreased zfPGRN-A translation, zfPGRN-       Supplementary Videos 7 8). <br />  A-MO mRNA resulted normal zfPGRN-A translation. <br />  (C) Control experiments showing results injection of <br />                                                                        zfPGRN-A reverses smn1 knockdown phenotype <br />  100pg hPGRN mRNA 1ng gfp mRNA demonstrating translation <br />  protein both.                                                vivo <br />                                                                        To determine zfPGRN-A modulates actions <br />                                                                        factors known modify MN developmental fate, we <br />                                                                        investigated ability zfPGRN-A rescue defects in <br /> PGRN-A stimulates motoneuron branching rescues                     previously characterised motoneuron developmental <br /> the truncation defects resulting knockdown                     pathways. Two pathways chosen; knockdown <br /> PGRN-A expression                                                      Survival Motorneuron-1 SMN1, protein with <br /> Ectopic expression zfPGRN-A mRNA                          important roles spliceosomal small nuclear ribonu- <br /> hPGRN mRNA increased incidence branching                        cleoprotein biogenesis axon outgrowth [40] and <br /> (Figure 5, Panels C D; Figure 6) causing                   Neuropilin 1a, semaphorin co-receptor interacts <br /> truncation defects. Co-injection zfPGRN-A                    mediators semaphorin pathway reg- <br /> mRNA hPGRN mRNA zfPGRN-A                              ulate axonal guidance [41]. Mutations human SMN1 <br /> MO1 2 significantly reduced incidence trun-                  known cause spinal muscular atrophy (SMA) <br /> cated neurons suggesting zfPGRN-A necessary                    [42], common genetic cause early lethality <br /> for normal CaP MN development (Figure 5, Panels G                      children abnormal variants implicated <br /> and H; Figure 6, Panel A). In addition, co-injection               sporadic ALS [43]. MO-induced knockdown SMN <br /> of zfPGRN-A mRNA hPGRN mRNA                             resulted truncated aberrantly branched CaP neu- <br /> zfPGRN-A MO 1 2 increased incidence early                    rons that, reported previously, reproduce aspects of <br /> and late branching compared MO injection.                      human SMA [35], (Figure 7, Panels A B). Co-injec- <br /> These studies suggest zfPGRN-A promotes neuro-                    tion smn1 MO zfPGRN-A mRNA reversed <br /> nal outgrowth vivo (Figure 5, Panels C, D, G H;                 truncation defects. Branching increased relative to <br /> Figure 6, Panel B). The phenotypes validated                   results obtained MO (Figure 7 Panel C). <br /> each category 3 independent experiments                      Phenotypes validated using 50 embryos in <br /> sample sizes 20 (WT, Control, PGRN MO1,                    category data presented histograms in <br /> PGRN MO2, PGRN MO2 plus PGRN-A mRNA                                Figure 8, Panels A B. To determine rescue effect <br /> PGRN MO2 plus hPGRN mRNA).                                             PGRN reversing motoneuron defects smn1 <br />  Chitramuthu et al. Molecular Neurodegeneration 2010, 5:41                                                              Page 6 13 <br /> http://www.molecularneurodegeneration.com/content/5/1/41 <br />  <br />  <br />  <br />  <br />                                                                       mRNA increased branching versus NRP-1a MO alone <br />                                                                       (Figure 9, Panel C) did prevent multiple exits or <br />                                                                       displaced neurons. <br />  <br />                                                                       Discussion <br />                                                                       While known PGRN cytoprotective neu- <br />                                                                       rons vitro [29,30], partial loss results neuro- <br />                                                                       degeneration FTLD-U [14,16] little known how <br />                                                                       PGRN affects neurons vivo. Here employed zebra- <br />                                                                       fish investigate important question. The zebrafish <br />                                                                       harbors extended PGRN gene family dis- <br />                                                                       tinct members [32]. Both grna grnb encode precur- <br />                                                                       sors structurally homologous single human gene <br />                                                                       expressed CNS. High maternal <br />                                                                       expression grnb observed. In addition, grna is <br />                                                                       expressed maternally lower levels and <br />                                                                       expression increases time [32]. The GRN <br />                                                                       genes grn1 grn2 expressed weakly 48 hpf and <br />  Figure 4 zfPGRN-A knockdown results disrupted                     strongly expressed intestine and <br />  development multiple neural structures. Lateral views          pharyngeal region 3 dpf [32]. We focused <br />  whole-mount embryos probed islet 1 36 hpf. (A), uninjected   study grna (1) true orthologue of <br />  embryos (B) embryos injected zfPGRN-A MO2 (C) embryos <br />  injected 100 pg zfPGRN-A mRNA, (D) embryos co-injected <br />                                                                       single human gene (2) expressed the <br />  zfPGRN-A MO2 + 100 pg zfPGRN-A. 96% (48/50) uninjected       CNS (3) lower level maternal expression may <br />  embryos (A) 90% (45/50) embryos injected 100 pg          result severe phenotypes expression is <br />  zfPGRN-A mRNA (B) showed islet1 expression developing         knocked down. We observed expression grna <br />  hypothalamus, retinal ganglia, sensary ganglia pharyngeal        occurs neural development retina, hind- <br />  arches. 84%(31/37) embryos injected 10 ng zfPGRN-A <br />  MO2 (C) showed disrupted development multiple neural <br />                                                                       brain, tectum (Figure 1 2) depletion of <br />  structures. Co-injection embryos 10 ng MO2 100 pg        zfPGRN-A results general disruption neuronal <br />  zfPGRN-A mRNA (D) resulted rescue 80% (40/50) embryos      development assessed islet-1 marker during <br />  displaying islet 1 positive neural populations. Scale Bar = 100 &#206;&#188;m   24 hpf (Figure 4, data not <br />                                                                       shown). Following finding mouse motor neu- <br />                                                                       rons express PGRN [30] examined expression of <br /> knockdown functional level tested embryo                  zfPGRN-A mRNA protein levels deter- <br /> touch response avoidance swimming behaviour 48                    grna expressed zebrafish MNs. <br /> hrs post injection. While smn1 knockdown embryos                  Both caudal primary (CaP) motoneurons (MNs) and <br /> do strong avoidance swimming phenotype                   somatic boundaries express zfPGRN-A per- <br /> typical wild-type larvae, embryos co-injected             iod (Figure 1 2) confirming spatiotemporal <br /> either zfPGRN-A hPGRN improved avoid-                      distribution zfPGRN-A consistent role in <br /> ance swimming phenotype compared                         development MNs. zfPGRN-A generated the <br /> resulting knockdown smn1 (Additional File 2,                  somatic boundary provide paracrine stimulus for <br /> Supplementary Table S1; Additional Files 11, 12, 13,                  MN development, intrinsic MN expression of <br /> Supplementary Videos 9-11). It interesting                 zfPGRN-A serve autocrine function. The extent <br /> note 85 percent embryos co-injected                PGRN containing compartment, namely <br /> either zfPGRN-A hPGRN smn1 MO                        MNs somatic boundary contribute MN <br /> survived 24 hrs post injection smn1 knock-                development serve distinct overlap- <br /> down embryos showed 50 percent survival 24 hrs                   ping functions developmental process remains <br /> post injection. These studies suggest PGRN pro-               unclear present. <br /> tective MN truncation observed model                    The developing zebrafish MN provides advan- <br /> of SMA confirms PGRN potent stimulator                  tageous study ontogeny individual ver- <br /> of neuronal branching vivo. As reported previously                 tebrate neurons vivo real time. Primary MNs <br /> [36] MO-induced knockdown NRP-1a mRNA causes                       initiate common pathway shared classes <br /> multiple exits, branching displaced MNs                       primary motoneuron &#226;&#8364;&#339;choice point&#226;&#8364;? the <br /> resulted truncation defects (Figure 9, Panels A                 growth cones pause contact group spe- <br /> and B). Co-injection NRP1a MO zfPGRN-A                        cialized cells called muscle pioneers horizontal <br />  Chitramuthu et al. Molecular Neurodegeneration 2010, 5:41                                                                         Page 7 13 <br /> http://www.molecularneurodegeneration.com/content/5/1/41 <br />  <br />  <br />  <br />  <br />  Figure 5 Progranulin modulates motoneuron development vivo: zfPGRN-A knockdown induced CaP MN defects partially <br />  rescued zfPGRN-A hPGRN mRNA. Lateral views (anterior left; dorsal top) embryos labelled znp1 mAb 27 hpf <br />  (A) wild type embryos, (B) embryos injected Control MO, (C) 100 pg zfPGRN-A mRNA, (D) 100 pg hPGRN mRNA, (E) zfPGRN-A MO1, (F) <br />  zfPGRN-A MO2, (G) zfPGRN-A MO2+100 pg zfPGRN-A mRNA (H) zfPGRN-A MO2+100 pg hPGRN mRNA. Observed phenotypes normal <br />  MN development (A, B), increase branched axons (C-H), truncation axons (E, F) partial rescue truncated MNs (G, H). Dashed lines <br />  represent horizontal myoseptum. Abbreviations: T-truncation; B-Branching. Scale Bar = 50 &#206;&#188;m. <br />  <br />  <br /> myoseptum [34] location indicated                          tissues cells impacted undertaking <br /> dashed horizontal line lateral views zebrafish                 mRNA over-expression rescue experiments. <br /> embryos shown Figures 5, 7 9. After pausing,                        Knockdown zfPGRN-A generated truncation CaP <br /> each growth cone, turn, selects different pathway                   neurons indicative role formation MNs. <br /> that leads specific population muscle cells. The                 Co-injection zfPGRN-A hPGRN mRNA with <br /> CaP growth cones continue grow ventral direc-                    zfPGRN-A MO2 resulted partial rescue (Figures 5 <br /> tion. Development CaP neurons examined                        6). Wild type development CaP neurons shows <br /> whole-mount embryos 26-28 hpf visualized                          branching horizontal myoseptum, how- <br /> immunostaining using MN marker znp1. Experi-                         over-expression zfPGRN-A hPGRN increased <br /> ments designed test consequences 1)                       branching horizontal myo- <br /> zfPGRN-A over-expression 2) zfPGRN-A knockdown                           septum. Since ectopic expression injected mRNA is <br /> and 3) rescue zfPGRN-A knockdown zfPGRN-A                          ubiquitous (Additional File 1) reflect loss <br /> mRNA. In addition ability human PGRN                              topographical specificity PGRN stimulation the <br /> (hPGRN) mRNA reproduce actions zfPGRN-                         developing MN. The disruption MN structures <br /> A tested. Rescue experiments involved co-                        caused depleting zfPGRN-A translation paralleled <br /> injection zfPGRN-A MO2 zfPGRN-A                            changes gross motility touch <br /> mRNA hPGRN mRNA. Since UTR sequence                               response remains intact touch-evoked swimming is <br /> adjacent initiator AUG targeted                    greatly impaired (Additional File 2, Supplementary <br /> MO absent exogenous zfPGRN-A mRNA,                           Table S1; Additional Files 3, 4, 5, 6, Supplementary <br /> translation injected mRNA unaffected                    Videos 1-4). The motility defect partially rescued <br /> co-injected MO. To control appearance                         embryos co-injected either <br /> developmental defects potentially resulting                     zfPGRN-A hPGRN zfPGRN-A MO. <br /> injection expression exogenous protein                    (Additional File 2, Supplementary Table S1, Additional <br /> associated experimental manipulations, mRNA encod-                       Files 7 8, Supplementary Videos 5 6). These <br /> ing GFP injected embryos 1-2 cell                        results imply (i) PGRN required normal MN <br /> stage. The expression GFP fluorescence fol-                       development (ii) PGRN stimulates neuronal branch- <br /> lowed (Additional File 1). At 24 hpf gross develop-                   ing vivo (iii) context zfPGRN and <br /> mental changes observed importantly                         hPGRN functionally equivalent. These results not <br /> GFP widely expressed suggesting pertinent                   establish PGRN acts directly MNs or <br />  Chitramuthu et al. Molecular Neurodegeneration 2010, 5:41                                                                            Page 8 13 <br /> http://www.molecularneurodegeneration.com/content/5/1/41 <br />  <br />  <br />  <br />  <br />                                                                            conditions suggests direct effect PGRN upon <br />                                                                            developing MN [29,30]. <br />                                                                               Interestingly, unlike zebrafish, knockout of <br />                                                                            GRN mice does result marked MN defects <br />                                                                            [44]. This surprising given abundant <br />                                                                            expression PGRN murine MNs, ability regu- <br />                                                                            late neurite extension survival murine MN cells <br />                                                                            culture [29,30], association GRN mutations <br />                                                                            amyotrophic lateral sclerosis putative suscept- <br />                                                                            ibility factor [45] results obtained zebra- <br />                                                                            fish model reported present study. We suspect <br />                                                                            implies existence highly redundant survi- <br />                                                                            val mechanisms respect mammalian MNs which <br />                                                                            comparison zebrafish counterparts both <br />                                                                            exceptionally elongated long-lived. <br />                                                                               Since results indicate novel role zfPGRN-A <br />                                                                            spinal cord MN development branching we <br />                                                                            investigated zfPGRN-A interact with <br />                                                                            factors known regulate MN develop- <br />                                                                            ment. zfPGRN-A mRNA expression reversed trunca- <br />  Figure 6 Progranulin knockdown over-expression <br />  validation: Average number Truncated (A) Branched (B) CaP          tion defects brought smn1 knockdown vivo. <br />  MNs (n&#226;&#8240;&#165;50/group). Values expressed mean &#194;&#177; standard error          Intriguingly TDP-43 SMN involved with <br />  mean. Statistical analyses one-way ANOVA            RNA processing stabilization. That PGRN asso- <br />  followed student-Newman-keuls Multiple Comparisons Test (p &lt;           ciated biologically TDP-43 [13] smn1 <br />  0.001-***, p &lt; 0.01-**, p &lt; 0.05-*). Error bars represent s.e.m. <br />                                                                            (Figure 7, 8) indicate shared pathways their <br />  Abbreviations: WT, wild type; Control-MO, Control Morpholino; <br />  zfPGRN-A, zebrafish PGRN-A mRNA; hPGRN, human progranulin;                respective pathologies. It noteworthy deple- <br />  MO1, Morpholino directed initiator codon ATG; MO2,            tion zfPGRN-A, snm1, reported TDP-43 <br />  Morpholino directed 5&#226;&#8364;&#8482;UTR.                                    reported [46] results similar MN <br />                                                                            phenotype truncation excess branching. <br />                                                                            Knockdown NRP-1a, semaphorin co-receptor <br />                                                                            involved neuronal pathfinding, resulted multiple <br /> initiates cascade signals regulate MN develop-                   exits misplaced MNs truncation and <br /> ment indirectly. A definitive answer question                 spectrum defects reversible co-expres- <br /> require better understanding distribution                     sion zfPGRN-A. The excessive branching seen follow- <br /> properties PGRN receptors. However, over-expression                     ing depletion smn1 NRP-1a significantly <br /> of PGRN promotes neurite-like extensions monocul-                       exaggerated presence co-injected zfPGRN-A <br /> tures MNs MN cell lines highly defined                        mRNA providing evidence ability of <br />  <br />  <br />  <br />  <br />  Figure 7 Progranulin protects CaP MNs model Spinal Muscular Atrophy SMA): zfPGRN-A mRNA co-injection partially rescues SMN- <br />  MO induced CaP MN defects. (A, B) Lateral views embryos injected 9 ng SMN-MO (C) embryos co-injected 9 ng SMN-MO + <br />  100 pg zfPGRN-A mRNA. Symbols Figure 1. Truncated (A) branched (B) neurons observed injection SMN MO co- <br />  injection zfPGRN-A rescued truncation (white arrow) increased axon branching (C). Abbreviations: T-truncation; B-Branching. Scale Bar = <br />  50 &#206;&#188;m. <br />  Chitramuthu et al. Molecular Neurodegeneration 2010, 5:41                                                                     Page 9 13 <br /> http://www.molecularneurodegeneration.com/content/5/1/41 <br />  <br />  <br />  <br />  <br />  Figure 8 Validation rescue effect zfPGRN-A SMA model: Average number specified MN defects affected (n &#226;&#8240;&#165; 50/group). <br />  Statistical analyses performed one-way ANOVA followed student-Newman-keuls Multiple Comparisons Test (p &lt; 0.001-***, p &lt; <br />  0.01-**, p &lt; 0.05-*). Error bars represent s.e.m. Abbreviations: WT, wild type; zfPGRN-A, zebrafish PGRN-A mRNA; smn1-MO-co-injection of <br />  Morpholino directed initiator ATG Morpholino directed 5&#226;&#8364;&#8482;UTR. <br />  <br />  <br />  <br /> zfPGRN-A promote MN branching zebrafish                      suggests possible future roles therapy neurode- <br /> CaP developmental model.                                               generative conditions. <br />  <br /> Conclusions                                                            Materials methods <br /> PGRN regulates spinal cord MN development                          Fish husbandry <br /> branching. PGRN expressed zebrafish CaP                  Wild type zebrafish purchased Aquatica Tro- <br /> motoneuron development. PGRN knockdown                          picals (Florida) maintained 14 h/10 h light/ <br /> generates truncated CaP MNs premature                         dark cycle 28.5&#194;&#176;C laboratory aquarium (Allen- <br /> branching ectopic over-expression promotes                       town Caging Equipment Co. Inc., Allentown, NJ). Zeb- <br /> branching. zfPGRN-A mRNA rescues truncation defects                    rafish maintained according protocols approved <br /> in vivo. Consistent emerging appreciation                  McGill University animal Care Committee (Protocol <br /> the neuroprotective properties PGRN [29,30],                        Number 3935). Fish fed twice daily. In late <br /> zfPGRN-A over-expression reverses truncation effect                afternoon day embryos required <br /> of SMN knockdown, mutations cause SMA                      (approximately 3:00 p.m.), fish transferred net <br /> humans. This study presents vivo demonstra-               positioned holding tank cov- <br /> tion neurotrophic properties PGRN                        ered. In morning, light cycle begins and <br />  <br />  <br />  <br />  <br />  Figure 9 Co-injection zfPGRN-A mRNA exaggerated NRP1a-MO induced Cap MN defects particularly branching. (A, B) Embryos <br />  injected NRP1a-MO (C) co-injected NRP1a-MO + 100 pg zfPGRN-A. Multiple exits (A, C), Branched motor axons (B C), and <br />  displaced neurons (B, C) observed. Abbreviations: ME, Multiple Exits; DN, Displaced Neurons; B, Branching. Scale Bar = 50 &#206;&#188;m. <br />  Chitramuthu et al. Molecular Neurodegeneration 2010, 5:41                                                  Page 10 13 <br /> http://www.molecularneurodegeneration.com/content/5/1/41 <br />  <br />  <br />  <br />  <br /> spawning stopped, eggs fallen     consisting V5 epitope 6&#195;&#8212;Histidine. The <br /> the net collected the tank.         authenticity construct verified DNA <br /> Embryos used developmental studies col-      sequencing. Other vectors used full-<span id='am-3' about='xsp:length' typeof='owl:Thing'>length</span> <br /> lected staged hours post fertilization (hpf) [47].   hPGRN/pcDNA37and GFP/pcDNA3 (Invirogen). For the <br />                                                             zfPGRN-A rescue experiments MO directed against <br /> Whole-mount zebrafish In situ hybridization                 5&#226;&#8364;&#178;UTR region zfPGRN-A (MO2). The construct <br /> Analysis gene expression ISH carried          mRNA microinjection does contain untrans- <br /> essentially previously described [32] using zfPGRN-A     lated 5&#226;&#8364;&#178; sequence zfPGRN-A. Hence possi- <br /> and Islet 1 sense anti-sense DIG-labelled riboprobes.   bility binding mRNA morpholino <br /> Stained whole-mount embryos mounted glycerol        co-injected. Translation enhanced capped <br /> and visualized Leica MZFLIII stereomicroscope.      mRNA synthesized mMessage mMachine <br /> Pictures taken Leica DC350F camera          Kit (Ambion, Huntingdon, England). For mRNA overex- <br /> processed Adobe Photoshop 7.0 software.                pression rescue experiments 100 pg either <br />                                                             zfPGRN-A hPGRN mRNA used. Microinjection <br /> Embryo microinjection morpholino oligonucleotides        1 ng GFP mRNA used control to <br /> Morpholino oligonucleotides (MO) obtained         demonstrate microinjection over-expression <br /> Gene Tools, Inc. (Philomath, OR) diluted             does inherently affect development. GFP/pcDNA3 <br /> Danieaux buffer (58 mM NaCl, 0.7 mM KCl, 0.4 mM             vector transcribed injected 1 ng per <br /> MgSO4, 0.6 mM Ca(NO3) 2 , 5.0 mM Hepes pH 7.6)              embryo GFP signal observed the <br /> containing 0.05% phenol red [48]. Approximately 2 nL        enhanced GFP filter using Leica MZFLIII stereomicro- <br /> of Morpholino 0.05% FITC-dextran (Sigma-         scope. The fluorescent GFP signal observed uni- <br /> Aldrich, Oakville, ON, Canada) injected        formly body confirming mRNA <br /> yolk 1- 2-cell stage embryos using PLI-100          intact translated protein. <br /> microinjection (Harvard Apparatus, St. Laurent, <br /> QC, Canada). Phenotype observation documenta-           Immunohistochemistry/immunofluorescence <br /> tion accomplished using Leica DC300F digital         Embryos (approximately 24 hpf) grown egg water (water <br /> camera connected Leica MZFLIII stereomicroscope        commercially available salt solution, 0.6% <br /> and processed Adobe Photoshop 7.0 software. The        Instant Ocean) supplemented 0.003% phenylthio- <br /> sequence MO directed initiator AUG        carbamide (PTC) prevent appearance melanin pig- <br /> zfPGRN-A (MO1) 5&#226;&#8364;&#178;GAGGCAGACTGTCAGT                       mentation. Staged embryos manually dechorionated <br /> CTCAACATT3&#226;&#8364;&#178; sequence MO corre-               fixed 2 hours room temperature overnight at <br /> sponding 5&#226;&#8364;&#178;UTR region zfPGRN-A (MO2)          4&#194;&#176;C 4% paraformaldehyde (PFA)/Phosphate Buffered sal- <br /> 5&#226;&#8364;&#178;GAGCAGGTGGATTTGTGAACAGCGG3&#226;&#8364;&#178;. The                          ine (PBS). After washes PBS, embryos stored <br /> sequence MO corresponding 5&#226;&#8364;&#178;UTR region        100% methanol required. Rehydration embryos <br /> of zfPGRN-B 5&#226;&#8364;&#178; TACAGATGAAAAGCCATGAAC-                   performed 5 min periods successive solutions of <br /> GACT3&#226;&#8364;&#178;. MOs directed initiator AUG           Methanol/PBS Tween (PBST) 3 times in <br /> smn1 (5&#226;&#8364;&#178;CGACATCTTCTGCACCATTGGC3&#226;&#8364;&#178;),                      PBST. Embryos permeabilized proteinase K <br /> UTR sequences smn1 (5&#226;&#8364;&#178;TTTAAATATTTCC-                     diluted PBST final concentration 10 &#206;&#188;g/ml. Post <br /> CAAGTCCAACGT3&#226;&#8364;&#178;) NRP1a (5&#226;&#8364;&#178;GAATCCTG-                      fixation carried 4% PFA/PBS 20 min at <br /> GAGTTCGGAGTGCGGAA3&#226;&#8364;&#178;) used. For                    room temperature followed 3 rinses PBST. Embryos <br /> Morpholino injection 10 ng zfPGRN-A, 9 ng smn1           incubated blocking buffer (5% Calf Serum, 1% <br /> (both MOs together) 8 ng NRP1a used.         DMSO PBST) 3-5 hours. Embryos incu- <br />                                                             bated znp1 (ZIRC) monoclonal antibody (1:200), a <br /> Microinjection PGRN mRNA                                 marker motor neurons (MNs), Spinal cord, retinal and <br /> For zfPGRN-A mRNA over-expression rescue                hindbrain axons zfPGRN-A polyclonal antibody raised <br /> experiments full-length zfPGRN-A/pcDNA3 vector            synthetic peptide corresponding residues 242 to <br /> was generated follows: The full-length zfPGRN-A          256 zfPGRN-A (RAEWEDHKQKKPETQC; synthesized <br /> sequence purchased RZPD (Berlin, Germany)          solid-phase chemistry Sheldon Biotechnology <br /> as clone UCDMp574E2318Q2 subcloned                 Centre McGill University carboxyl-terminal <br /> pcDNA3.1-V5/His vector (Invitrogen, Carlsbad, CA)           cysteine facilitate conjugation) diluted 1:500 <br /> using forward primer overlapped starter     blocking buffer. Incubations carried overnight <br /> AUG reverse primer read termi-       4&#194;&#176;C followed washes PBST. Embryos incubated <br /> nation codon. The final vector construct consisted       anti-znp1 treated Goat anti-Mouse AP <br /> full-length zfPGRN-A carboxyl-terminal tag           conjugate (Calbiochem) secondary antibody diluted to <br />  Chitramuthu et al. Molecular Neurodegeneration 2010, 5:41                                                               Page 11 13 <br /> http://www.molecularneurodegeneration.com/content/5/1/41 <br />  <br />  <br />  <br />  <br /> 1:1000 blocking buffer PBST 2 hr room tem-      thawed 30 uL 2&#195;&#8212; Laemmli buffer was <br /> perature. Embryos incubated anti-zfPGRN-A            added extracts boiled 5 minutes. Embryo <br /> then incubated Alexa488 conjugated anti-rabbit anti-      extracts resolved 10% acrylamide gels 2 <br /> body diluted 1:1000 blocking buffer PBST 2      embryo equivalents lane transferred nitro- <br /> hr room temperature. Embryos incubated        cellulose membrane. The blots incubated in <br /> secondary antibodies washed times PBST.            PBST 1:4000 anti-zfPGRN-A 1:10000 anti- <br /> Embryos destined used visualize znp1 labelling        hPGRN (R&amp;D System) 1:1000 anti-GFP (Open Bio- <br /> were incubated staining buffer (100 mM Tris-HCl pH          systems) 1 hour followed extensive washing. <br /> 9.5, 50 mM MgCl2, 100 mM NaCl, 0.1% Tween-20,1 mM              After incubating anti-rabbit anti-goat IgG- <br /> levamisol) colour developed NBT BCIP-T            horseradish peroxidase (HRP)-conjugated secondary <br /> (Fermentas). After 30 min staining reaction stopped    antibody (diluted 1:4,000) room temperature 1 <br /> and Caudal primary motor neurons (Cap MNs)          hour blots visualized using enhanced chemilumi- <br /> trunk (excluding tail region) embryos visua-   nescence (GE Healthcare) according manufac- <br /> lized Olympus inverted phase contrast micro-          turer&#226;&#8364;&#8482;s instructions. Equivalence protein loading per <br /> scope. Pictures taken Olympus DP12 camera         lane determined staining mouse monoclo- <br /> and processed Adobe Photoshop 7.0 software. The           nal b-actin antibody (AC-40; Sigma) dilution of <br /> zfPGRN-A immunofluorescence visualized Leica        1:1000 followed 1:4000 anti-mouse IgG-horseradish <br /> MZ FLIII stereomicroscope equipped GFP filter,          peroxidase (HRP)-conjugated secondary antibody. The <br /> photographed processed Adobe Photoshop 7.0            rabbit polyclonal anti-zfPGRN-A raised against <br /> software.                                                      synthetic peptide corresponding residues 242 256 <br />                                                                zfPGRN-A (RAEWEDHKQKKPETQC), residues <br /> Analysis Caudal Primary Motoneurons (CaP MNs)               153 173 zebrafish progranulin-B (CGSSPFL <br /> Caudal primary motor axons whole-mounted 26-28              RKFAARRRKPLEKNA), respectively (Sheldon Biotech- <br /> hpf embryos labelled Znp1 monoclonal antibody             nology Centre). Epitope-specific immunoglobulin was <br /> were analyzed. Only trunk CaP MNs (12 pairs)          purified affinity chromatography. The specificity of <br /> scored [36]. In wild type embryos grown       western blot immunoreactive bands confirmed by <br /> beyond ventral edge notochord ven-         blocking incubations synthetic zfPGRN-A and <br /> tral somite 24 hpf. Trunk hemisegments scored          zfPGRN-B peptides. <br /> as &#226;&#8364;&#732;branched&#226;&#8364;&#8482; nerves branched above <br /> the ventral edge notochord. This strategy           Additional material <br /> employed exclude naturally occurring branching that <br /> is observed ventral notochord. Trunk           Additional file 1: In vivo translation 1 ng gfp mRNA. (A) bright <br /> hemisegments scored &#226;&#8364;&#732;truncated&#226;&#8364;&#8482;               field image showing developmental abnormalities (B) widespread <br />                                                                 appearance gfp signal developing embryo 27 hpf. <br /> nerves did grow horizontal myoseptum. <br />                                                                 Additional file 2: Supplementary Table S1: Summary survival <br /> When znp1 immunolabeled axon fascicle             swimming behaviour embryos shown videos 1-11 <br /> exited spinal cord scored multiple exit.      (Additional Files 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13). <br /> Embryos counted respect            Additional file 3: Video 1: Touch-evoked swimming behaviour of <br /> nerves 12 pairs demonstrated particular        wild-type embryo 48 hpf. <br /> defect. For treatment experiments           Additional file 4: Video 2: Reduced motility zfPGRN-A deficient <br />                                                                 embryos swim away compared wild-type embryos 48 <br /> were performed 50 embryos scored              hpf. <br /> per determination. Values expressed mean &#194;&#177;              Additional file 5: Video 3: Touch-evoked swimming behaviour of <br /> standard error mean.                                     wild-type embryo 72 hpf. <br />                                                                 Additional file 6: Video 4: Inability zfPGRN-A deficient embryos <br /> Statistics                                                      swim away compared wild-type embryos 72 hpf. <br /> Statistical significance experimental groups          Additional file 7: Video 5: Embryos co-injected zfPGRN-A <br />                                                                 mRNA PGRN-A MO rescued motility (48 hpf). <br /> determined one-way analysis variance (ANOVA), <br />                                                                 Additional file 8: Video 6: Embryos co-injected hPGRN mRNA <br /> followed Newman-Keuls multiple comparison                PGRN-A MO rescued motility (48 hpf). <br /> test. Error bars represent s.e.m. Calculation per-          Additional file 9: Video 7: Embryos over-expressing zfPGRN-A show <br /> formed using GraphPad software (GraphPad Software               strong avoidance swimming behaviour (48 hpf). <br /> Inc., San Diego, CA).                                           Additional file 10: Video 8: Embryos over-expressing hPGRN a <br />                                                                 strong avoidance swimming behaviour (48 hpf). <br /> Western blot Zebrafish Embryos                               Additional file 11: Video 9: smn1 knockdown embryos show <br />                                                                 strong avoidance swimming phenotype typical wild-type <br /> At 24 hpf embryos manually de-yolked fro-              larvae (48 hpf). <br /> zen liquid nitrogen stored -80C. Samples <br />  Chitramuthu et al. Molecular Neurodegeneration 2010, 5:41                                                                                        Page 12 13 <br /> http://www.molecularneurodegeneration.com/content/5/1/41 <br />  <br />  <br />  <br />  <br />                                                                                       neutrophil elastase enhance inflammation mice inactivating <br />  Additional file 12: Video 10: Smn1 knockdown embryos co-injected                     antiinflammatory progranulin. J Clin Invest 2008, 118:2438-2447. <br />  zfPGRN-A mRNA improved avoidance swimming                         10.   Bai XH, Wang DW, Kong L, Zhang Y, Luan Y, Kobayashi T, Kronenberg HM, <br />  phenotype compared resulting knockdown                          Yu XP, Liu CJ: ADAMTS-7, direct target PTHrP, adversely regulates <br />  smn1 (48 hpf).                                                                       endochondral bone growth associating inactivating GEP <br />  Additional file 13: Video 11: Smn1 knockdown embryos co-injected                     growth factor. Mol Cell Biol 2009, 29:4201-4219. <br />  hPGRN mRNA improved avoidance swimming                            11.   Daniel R, He Z, Carmichael KP, Halper J, Bateman A: Cellular localization of <br />  phenotype compared resulting knockdown                          gene expression progranulin. J Histochem Cytochem 2000, 48:999-1009. <br />  smn1 (48 hpf).                                                                 12.   Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, <br />                                                                                       Tsuchiya K, Yoshida M, Hashizume Y, Oda T: TDP-43 component of <br />                                                                                       ubiquitin-positive tau-negative inclusions frontotemporal lobar <br />                                                                                       degeneration amyotrophic lateral sclerosis. Biochem Biophys Res <br /> Acknowledgements                                                                      Commun 2006, 351:602-611. <br /> The authors acknowledge financial support Neurodyn Inc.          13.   Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, <br /> Canadian Institutes Health Research thank Dr. Pierre Drapeau,                 Bruce J, Schuck T, Grossman M, Clark CM, et al: Ubiquitinated TDP-43 in <br /> Department Pathology Cell Biology, University Montreal help             frontotemporal lobar degeneration amyotrophic lateral sclerosis. <br /> with recording movies zebrafish embryos.                                           Science 2006, 314:130-133. <br />                                                                                 14.   Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, <br /> Author details                                                                        Lindholm C, Snowden J, Adamson J, Sadovnick AD, Rollinson S, et al: <br /> 1 <br />  Endocrine Research Laboratory Department Medicine, Royal Victoria             Mutations progranulin cause tau-negative frontotemporal dementia <br /> Hospital McGill University Health Centre Research Institute, Montreal,            linked chromosome 17. Nature 2006, 442:916-919. <br /> Quebec, H3A 1A1, Canada. 2Neurodyn Inc., Suite 508, NRC-INH, 550                15.   Gijselinck I, Van Broeckhoven C, Cruts M: Granulin mutations associated <br /> University Avenue, Charlottetown, Prince Edward Island, C1A 4P3, Canada.              frontotemporal lobar degeneration related disorders: an <br />                                                                                       update. Hum Mutat 2008, 29:1373-1386. <br /> Authors&#226;&#8364;&#8482; contributions                                                          16.   Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H, Pirici D, <br /> BPC designed conducted experiments, analyzed data                 Rademakers R, Vandenberghe R, Dermaut B, Martin JJ, et al: Null mutations <br /> wrote manuscript. DCB participated preliminary studies                progranulin cause ubiquitin-positive frontotemporal dementia linked <br /> morpholino knockdowns design study. DGK participated             chromosome 17q21. Nature 2006, 442:920-924. <br /> the design study. AB HPJB co-ordinated design study       17.   Josephs KA: Frontotemporal lobar degeneration. Neurol Clin 2007, <br /> and writing manuscript. HPJB conceived study. All authors           25:683-696, vi. <br /> read approved final manuscript.                                         18.   Snowden JS, Pickering-Brown SM, Mackenzie IR, Richardson AM, Varma A, <br />                                                                                       Neary D, Mann DM: Progranulin gene mutations associated with <br /> Competing interests                                                                   frontotemporal dementia progressive non-fluent aphasia. Brain 2006, <br /> The research reported manuscript supported work               129:3091-3102. <br /> supported Neurodyn Inc. HPJB member Scientific Advisory      19.   Gass J, Cannon A, Mackenzie IR, Boeve B, Baker M, Adamson J, Crook R, <br /> board Neurodyn.                                                                    Melquist S, Kuntz K, Petersen R, et al: Mutations progranulin major <br />                                                                                       cause ubiquitin-positive frontotemporal lobar degeneration. Hum Mol <br /> Received: 30 August 2010 Accepted: 14 October 2010                                    Genet 2006, 15:2988-3001. <br /> Published: 14 October 2010                                                      20.   Cruts M, Van Broeckhoven C: Loss progranulin function in <br />                                                                                       frontotemporal lobar degeneration. Trends Genet 2008, 24:186-194. <br />                                                                                 21.   Vossel KA, Miller BL: New approaches treatment frontotemporal <br /> References                                                                            lobar degeneration. Curr Opin Neurol 2008, 21:708-716. <br /> 1. Bhandari V, Palfree RG, Bateman A: Isolation sequence granulin    22.   Jellinger KA: Neuropathological aspects Alzheimer disease, Parkinson <br />     precursor cDNA human bone marrow reveals tandem cysteine-rich                disease frontotemporal dementia. Neurodegener Dis 2008, 5:118-121. <br />     granulin domains. Proc Natl Acad Sci USA 1992, 89:1715-1719.                23.   Williams A, Jahreiss L, Sarkar S, Saiki S, Menzies FM, Ravikumar B, <br /> 2. Bateman A, Bennett HP: The granulin gene family: cancer                    Rubinsztein DC: Aggregate-prone proteins cleared cytosol <br />     dementia. Bioessays 2009, 31:1245-1254.                                           autophagy: therapeutic implications. Curr Top Dev Biol 2006, 76:89-101. <br /> 3. Diaz-Cueto L, Gerton GL: The influence growth factors              24.   Yin F, Banerjee R, Thomas B, Zhou P, Qian L, Jia T, Ma X, Ma Y, Iadecola C, <br />     development preimplantation mammalian embryos. Arch Med Res                    Beal MF, et al: Exaggerated inflammation, impaired host defense, and <br />     2001, 32:619-626.                                                                 neuropathology progranulin-deficient mice. J Exp Med 207:117-128. <br /> 4. Daniel R, Daniels E, He Z, Bateman A: Progranulin (acrogranin/PC cell-       25.   Kayasuga Y, Chiba S, Suzuki M, Kikusui T, Matsuwaki T, Yamanouchi K, <br />     derived growth factor/granulin-epithelin precursor) expressed           Kotaki H, Horai R, Iwakura Y, Nishihara M: Alteration behavioural <br />     placenta, epidermis, microvasculature, brain murine                    phenotype mice targeted disruption progranulin gene. <br />     development. Dev Dyn 2003, 227:593-599.                                           Behav Brain Res 2007, 185:110-118. <br /> 5. Qin J, Diaz-Cueto L, Schwarze JE, Takahashi Y, Imai M, Isuzugawa K,          26.   Suzuki M, Lee HC, Kayasuga Y, Chiba S, Nedachi T, Matsuwaki T, <br />     Yamamoto S, Chang KT, Gerton GL, Imakawa K: Effects progranulin             Yamanouchi K, Nishihara M: Roles progranulin sexual differentiation <br />     blastocyst hatching subsequent adhesion outgrowth                  developing brain adult neurogenesis. J Reprod Dev 2009, <br />     mouse. Biol Reprod 2005, 73:434-442.                                              55:351-355. <br /> 6. Desmarais JA, Cao M, Bateman A, Murphy BD: Spatiotemporal expression         27.   Yin F, Dumont M, Banerjee R, Ma Y, Li H, Lin MT, Beal MF, Nathan C, <br />     pattern progranulin embryo implantation placenta formation              Thomas B, Ding A: Behavioral deficits progressive neuropathology in <br />     suggests role cell proliferation, remodeling, angiogenesis.              progranulin-deficient mice: mouse model frontotemporal dementia. <br />     Reproduction 2008, 136:247-257.                                                   FASEB J 2010. <br /> 7. He Z, Ong CH, Halper J, Bateman A: Progranulin mediator          28.   Ahmed Z, Sheng H, Xu YF, Lin WL, Innes AE, Gass J, Yu X, Hou H, Chiba S, <br />     wound response. Nat Med 2003, 9:225-229.                                          Yamanouchi K, et al: Accelerated lipofuscinosis ubiquitination in <br /> 8. Zhu J, Nathan C, Jin W, Sim D, Ashcroft GS, Wahl SM, Lacomis L, Erdjument-         granulin knockout mice suggest role progranulin successful <br />     Bromage H, Tempst P, Wright CD, Ding A: Conversion proepithelin             aging. Am J Pathol 177:311-324. <br />     epithelins: roles SLPI elastase host defense wound repair.    29.   Van Damme P, Van Hoecke A, Lambrechts D, Vanacker P, Bogaert E, van <br />     Cell 2002, 111:867-878.                                                           Swieten J, Carmeliet P, Van Den Bosch L, Robberecht W: Progranulin <br /> 9. Kessenbrock K, Frohlich L, Sixt M, Lammermann T, Pfister H, Bateman A,             functions neurotrophic factor regulate neurite outgrowth and <br />     Belaaouaj A, Ring J, Ollert M, Fassler R, Jenne DE: Proteinase 3              enhance neuronal survival. J Cell Biol 2008, 181:37-41. <br />  Chitramuthu et al. Molecular Neurodegeneration 2010, 5:41                                                                                     Page 13 13 <br /> http://www.molecularneurodegeneration.com/content/5/1/41 <br />  <br />  <br />  <br />  <br /> 30. Ryan CL, Baranowski DC, Chitramuthu BP, Malik S, Li Z, Cao M, Minotti S, <br />     Durham HD, Kay DG, Shaw CA, et al: Progranulin expressed within <br />     motor neurons promotes neuronal <span id='am-83' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-84' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-85' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-86' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-87' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-88' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-89' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-90' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-91' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-92' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-93' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-94' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-95' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-96' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-98' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-99' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-100' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-101' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-102' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-103' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-104' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-105' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-106' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-107' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-108' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-109' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-110' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-111' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-112' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-113' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-114' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-115' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-116' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-117' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-118' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-119' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-120' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-121' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-122' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-123' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-124' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-125' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-126' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-127' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-128' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-129' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-130' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-131' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-132' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-133' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-134' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-135' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-136' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-137' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-139' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-140' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-141' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-142' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-143' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-144' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-145' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-146' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-147' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-148' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-150' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-151' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-152' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-153' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-154' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-155' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-157' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-158' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-159' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-160' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span>cell survival</span>. BMC Neurosci 2009, <br />     10:130. <br /> 31. Lieschke GJ, Currie PD: Animal models human disease: zebrafish swim <br />     view. Nat Rev Genet 2007, 8:353-367. <br /> 32. Cadieux B, Chitramuthu BP, Baranowski D, Bennett HP: The zebrafish <br />     progranulin gene family antisense transcripts. BMC Genomics 2005, <br />     6:156. <br /> 33. Shankaran SS, Capell A, Hruscha AT, Fellerer K, Neumann M, Schmid B, <br />     Haass C: Missense mutations progranulin gene linked to <br />     frontotemporal lobar degeneration ubiquitin-immunoreactive <br />     inclusions reduce progranulin production secretion. J Biol Chem <br />     2008, 283:1744-1753. <br /> 34. Feldner J, Reimer MM, Schweitzer J, Wendik B, Meyer D, Becker T, <br />     Becker CG: PlexinA3 restricts spinal exit points branching trunk <br />     motor nerves embryonic zebrafish. J Neurosci 2007, 27:4978-4983. <br /> 35. McWhorter ML, Monani UR, Burghes AH, Beattie CE: Knockdown the <br />     survival motor neuron (Smn) protein zebrafish causes defects in <br />     motor axon outgrowth pathfinding. J Cell Biol 2003, 162:919-931. <br /> 36. Feldner J, Becker T, Goishi K, Schweitzer J, Lee P, Schachner M, <br />     Klagsbrun M, Becker CG: Neuropilin-1a involved trunk motor axon <br />     outgrowth embryonic zebrafish. Dev Dyn 2005, 234:535-549. <br /> 37. Tessier-Lavigne M, Goodman CS: The molecular biology axon guidance. <br />     Science 1996, 274:1123-1133. <br /> 38. Ozdinler PH, Macklis JD: IGF-I specifically enhances axon outgrowth of <br />     corticospinal motor neurons. Nat Neurosci 2006, 9:1371-1381. <br /> 39. Sanchez-Camacho C, Rodriguez J, Ruiz JM, Trousse F, Bovolenta P: <br />     Morphogens growth cone signalling molecules. Brain Res Brain Res Rev <br />     2005, 49:242-252. <br /> 40. Eggert C, Chari A, Laggerbauer B, Fischer U: Spinal muscular atrophy: the <br />     RNP connection. Trends Mol Med 2006, 12:113-121. <br /> 41. Kruger RP, Aurandt J, Guan KL: Semaphorins command cells move. Nat <br />     Rev Mol Cell Biol 2005, 6:789-800. <br /> 42. Alias L, Bernal S, Fuentes-Prior P, Barcelo MJ, Also E, Martinez-Hernandez R, <br />     Rodriguez-Alvarez FJ, Martin Y, Aller E, Grau E, et al: <span id='am-239' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-240' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-241' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-242' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-243' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-244' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-245' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-246' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-247' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-248' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-249' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-250' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-251' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-252' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-253' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-254' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-255' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-256' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-257' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-258' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-259' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-260' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-261' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-262' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-263' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-264' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-265' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-266' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-267' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-268' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-269' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-270' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-271' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-272' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-273' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-274' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-275' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-276' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-277' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-278' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-279' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-280' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-281' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-282' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-283' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-284' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-285' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-286' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-287' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-288' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-289' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-290' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-291' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-292' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-293' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-294' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-295' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-296' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-297' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-298' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-299' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-300' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-301' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-302' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-303' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-304' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-305' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-306' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-307' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-308' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-309' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-310' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-311' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-312' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-313' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-314' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-315' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-316' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span>Mutation</span> update of <br />     spinal muscular atrophy Spain: molecular characterization 745 <br />     unrelated patients identification novel mutations the <br />     SMN1 gene. Hum Genet 2009, 125:29-39. <br /> 43. Corcia P, Camu W, Praline J, Gordon PH, Vourch P, Andres C: The <br />     importance SMN genes genetics sporadic ALS. <br />     Amyotroph Lateral Scler 2009, 10:436-440. <br /> 44. Yin F, Dumont M, Banerjee R, Ma Y, Li H, Lin MT, Beal MF, Nathan C, <br />     Thomas B, Ding A: Behavioral deficits progressive neuropathology in <br />     progranulin-deficient mice: mouse model frontotemporal dementia. <br />     FASEB J . <br /> 45. Sleegers K, Brouwers N, Maurer-Stroh S, van Es MA, Van Damme P, van <br />     Vught PW, van der Zee J, Serneels S, De Pooter T, Van den Broeck M, et al: <br />     Progranulin genetic variability contributes amyotrophic lateral <br />     sclerosis. Neurology 2008, 71:253-259. <br /> 46. Kabashi E, Lin L, Tradewell ML, Dion PA, Bercier V, Bourgouin P, <br />     Rochefort D, Bel Hadj S, Durham HD, Vande Velde C, et al: Gain loss of <br />     function ALS-related mutations TARDBP (TDP-43) cause motor <br />     deficits vivo. Hum Mol Genet 19:671-683. <br /> 47. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF: Stages of <br />     embryonic development zebrafish. Dev Dyn 1995, 203:253-310. <br /> 48. Nasevicius A, Ekker SC: Effective targeted gene &#226;&#8364;&#732;knockdown&#226;&#8364;&#8482; zebrafish. <br />     Nat Genet 2000, 26:216-220. <br />                                                                                     Submit manuscript BioMed Central <br />  doi:10.1186/1750-1326-5-41 <br />                                                                                     advantage of: <br />  Cite article as: Chitramuthu et al.: Progranulin modulates zebrafish <br />  motoneuron development vivo rescues truncation defects <br />  associated knockdown Survival motor neuron 1. Molecular                    &#226;&#8364;&#162; Convenient online submission <br />  Neurodegeneration 2010 5:41.                                            <br /> </body></html>